Skip to main content

Jane Elizabeth Onken

Professor of Medicine
Medicine, Gastroenterology
Duke Box 3662, Durham, NC 27710
03137C Hosp South, Durham, NC 27710

Selected Grants


Interval Colonoscopy Screening for the Detection of Dysplasia in Inflammatory Bowel Disease

ResearchMentor · Awarded by American College of Gastroenterology · 2023 - 2024

DG29 SERES

Clinical TrialPrincipal Investigator · Awarded by Seres Therapeutics, Inc · 2019 - 2021

Boehringer Ingelheim Pharmaceuticals Inc - Industry - BI 655130 in Ulcerative Colitis Subjects

Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Corporation · 2019 - 2020

GS-US-326-1100 Dr. Onken Study

Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2015 - 2017

The Role of NAG-1 in Inflammatory Bowel Disease

Clinical TrialPrincipal Investigator · Awarded by National Institute of Environmental Health Sciences · 2008 - 2010

Bromelain-Based Biological Therapy for IBD

ResearchPhysician · Awarded by National Institutes of Health · 2004 - 2007

External Relationships


  • American Board of Internal Medicine
  • Arena Pharmaceuticals
  • Janssen Pharmaceuticals (Johnson & Johnson)
  • Merck & Co. USA (not assoc'd with Merck KGaA)
  • Pfizer Inc.

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.